Nasdaq saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 72 to 83.
IBD's unique RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
Decades of market research reveals that the best stocks often have an 80 or better RS Rating in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Nasdaq is trying to complete a consolidation with an 84.15 buy point. See if it can clear the breakout price in volume at least 40% above average.
While revenue growth fell last quarter from 31% to 23%, EPS grew 6%, up from 4% in the prior report. Keep an eye out for the company's next round of numbers on or around Apr. 24.
Nasdaq holds the No. 14 rank among its peers in the Financial Services-Specialty industry group. Sezzle, X Financial ADR and Marex Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
